市场调查报告书
商品编码
1439688
侧向层析阅读器/侦测 - 全球市场洞察、竞争格局、市场预测 (2030)Lateral Flow Readers/Assay - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2023 年,全球侧向层析阅读器/分析市场规模预计为86.4 亿美元,到2030 年将达到121.5 亿美元,2024-2030 年预测期间复合年增长率为5.41%。预计将会成长。 由于COVID-19的突然爆发等传染病发病率的增加以及全球妊娠测试数量的增加,该市场呈现正增长。 此外,免疫诊断产品领域的快速技术进步、人口的快速老化以及由于消费者对快速诊断的认识不断提高而对现场检测的需求不断增加是推动市场成长的关键因素。预测期为2024 年至2030年。
侧流阅读器/分析市场动态
由于多种原因,侧流阅读器/分析市场的产品需求正在增长,其中主要原因之一是世界范围内传染病的增加。 根据联合国爱滋病规划署发布的2022年数据,2020年全球约有3,770万人感染爱滋病毒,报告新增爱滋病毒感染者约150万例。 此外,用于检测和区分 HIV 感染以对 HIV 感染患者进行个人化管理的产品获得批准,正在推动侧流读取器/检测市场的成长。
推动侧向层析阅读器/检测市场成长的另一个因素是 COVID-19 大流行的爆发以及迫切需要诊断测试来遏制 COVID-19 的传播。 SARS-COV-2 病毒的高毒力引起了世界各地的恐慌,导致世界各地采取了不同阶段的封锁措施。 因此,迫切需要检测 SARS-COV-2 病毒的诊断方法和试剂盒,以便为感染者和未感染者提供更好的医疗保健。
此外,技术进步导致了许多快速抗原测试的发展,以满足对新的可靠诊断试剂盒的需求,以应对大流行的紧急情况,这种需求将在预测期内(2024年-2030年)持续成长,将积极影响侧流阅读器/分析市场的成长。 例如,2022 年 6 月,Novacyt 宣布进行两项 COVID-19 抗原侧向层析测试,扩大了其 COVID-19 产品组合,主要是在即时护理领域。
因此,为了促进各种传染病的诊断,对侧流读数器/检测的需求不断增加,从而导致整个侧流读数器/检测市场的成长。
因此,早期发现对于治疗至关重要。 适当的测试将带来更好的治疗。 因此,传染病的流行预计将导致对侧流读取器/检测的需求增加,从而促进侧流读取器/检测市场在2024-2030年预测期内的成长。
然而,开发准确的诊断测试和设备的挑战以及测试结果的可变性可能会对侧流读取器/分析市场的成长产生一定的限制。
侧流读取器/分析市场区隔分析
在侧流读取器/检测市场的产品领域中,试剂盒和试剂子领域预计在预测期内(2024-2030 年)将占较高占有率。 这可能是由于与这些产品相关的某些功能所造成的。
该细分市场的主导地位是由于这些产品的便携性。 试剂盒和试剂可靠且采用熟悉的格式,允许最终用户进行频繁的大规模测试。 这些产品不需要任何设备,是透过快速识别感染者并防止他们将疾病传播给其他人来管理风险的重要工具。 此外,一些市场参与者拥有强大的试剂盒和试剂组合,目前正在该领域推出新产品。
本报告提供了全球横向流动读取器/分析市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Lateral Flow Readers/Assay Market By Product (Readers [Bench-Top Readers, Digital/Mobile Readers], Kits & Reagents), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, Others], Drug Development & Quality Testing, Others), By End-User (Hospitals & Clinics, Home Care, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of infectious diseases and rapid technological advancements in the immunodiagnostic product arena
Global Lateral Flow Readers/Assay Market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030. The Lateral Flow Readers/Assay market is witnessing positive growth owing to the growing incidence of infectious diseases such as the sudden outbreak of COVID-19, and the increasing cases of pregnancy testing across the globe. Moreover, rapid technological advancements in the immunodiagnostic product arena, the rapidly aging population, increasing demand for point-of-care testing along rising consumer awareness regarding quick diagnostics, among others are some of the key factors responsible for the Lateral Flow Readers/Assay market growth, thereby contributing to the Global Lateral Flow Readers/Assay market during the forecast period from 2024-2030.
Lateral Flow Readers/Assay Market Dynamics:
The Lateral Flow Readers/Assay market is witnessing a growth in product demand owing to various reasons, one of the major reasons being the rising cases of infectious diseases across the globe. According to the 2022 data published by the UNAIDS, the Joint United Nations Programme on HIV/AIDS, an innovative joint venture of the United Nations family, approximately 37.7 million population globally were living with HIV and around 1.5 million new HIV cases were reported in the year 2020. Additionally, product approval for the detection and differentiation of HIV infection for personalized management of patients with HIV bolsters the Lateral Flow Readers/Assay market growth.
Another factor responsible for the growth of the Lateral Flow Readers/Assay market is the onset of the COVID-19 pandemic and the urgency felt for the need of the diagnostic tests in order to contain the spread of the COVID-19 infection. The high virulence associated with the SARS- COV-2 virus led to the panic situation across the globe and led to various stages of lockdowns globally. This led to the exigent need for diagnostic methods and kits for the detection of the SARS-COV-2 virus with the aim to design better care for both infected and uninfected population groups.
Moreover, technological advancements led to the development of numerous rapid antigen tests in order to serve the need for reliable novel diagnostic kits to meet the urgency created by the pandemic thereby positively impacting the Lateral Flow Readers/Assay market growth during the forecast period (2024-2030). For instance, in June 2022, Novacyt introduced two COVID-19 antigen lateral flow tests, expanding its COVID-19 product portfolio, mainly in the point-of-care segment.
Therefore, in order to facilitate the diagnosis of different infectious diseases, Lateral Flow Readers/Assay are witnessing an increase in demand, leading to overall Lateral Flow Readers/Assay market growth.
Hence, early detection is essential for a cure because survival is dependent on the treatment pathway for the disease. With proper testing, treatment becomes better. Therefore, the increasing prevalence of infectious diseases is projected to result in the growing demand for Lateral Flow Readers/Assay, thereby contributing to the growth of the Lateral Flow Readers/Assay market during the forecast period from 2024-2030.
However, challenges in the development of accurate diagnostic tests and equipment and variations in test findings may be certain limiting factors of the Lateral Flow Readers/Assay market growth.
Lateral Flow Readers/Assay Market Segment Analysis:
Lateral Flow Readers/Assay Market By Product (Readers [Bench-top Readers, Digital/Mobile Readers], Kits & Reagents), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, Others], Drug Development & Quality Testing, Others), By End-User (Hospitals & Clinics, Home Care, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product segment of the Lateral Flow Readers/Assay market, the Kits & Reagents subsegments are estimated to hold a higher share in the Lateral Flow Readers/Assay market during the forecast period (2024-2030). This can be attributed to the specific features associated with these products.
The dominance of this segment is due to the portability of these products. The Kits & Reagents are a reliable and familiar format that enables frequent mass testing among end-users. With no equipment required, these products are an important tool to manage risk by quickly identifying infectious people so they don't spread the disease to others. Moreover, several market players have a strong portfolio of Kits & Reagents and are now launching new products in this segment.
Furthermore, the increase in Emergency use Authorizations (EUA) test by the US FDA for the detection of COVID-19 will also contribute to the segmental growth. For instance, on August 26, 2020, Abbott received the US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its BinaxNOW(TM) COVID-19 Ag Card rapid test for detection of COVID-19 infection. It is highly portable, affordable, and provides results in 15 minutes.
Therefore, considering the advantages associated with Kits & Reagents, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Lateral Flow Readers/Assay market in the forecast period.
North America is expected to dominate the overall Lateral Flow Readers/Assay Market:
Among all the regions, North America is expected to account for the largest share in the Global Lateral Flow Readers/Assay market. Factors such as the growing burden of infectious disease in the region, presence of key market players, rising demand for technologically advanced point-of-care diagnostics platforms, increasing awareness for early detection among others are expected to aid in the growth of North America Lateral Flow Readers/Assay Market.
For instance, as per the data revealed by the Centres for Disease Control and Prevention (CDC) 2022, there were 37,377 people diagnosed with HIV in the US in the year 2018. Moreover, the data also revealed the new salmonella cases and Lyme disease cases in the region were 60,999 and 33,666 respectively in 2018.
Thus, the rising infectious disease burden in the regions will escalate the demand for the Lateral Flow Readers/Assay market.
In addition, the presence of global as well as regional manufacturers such as Qiagen, Roche, Abbott, among others active in developing the Lateral Flow Readers/Assay product will also boost the market. Also, improving healthcare infrastructure, and government initiatives in raising awareness regarding Lateral Flow Readers/Assay will contribute to the Lateral Flow Readers/Assay market growth in these regions.
Additionally, the presence of key manufacturers in the region and their strategic business activities will also contribute to the Lateral Flow Readers/Assay market growth. For instance, on August 25, 2022, Becton, Dickinson, and Company received the US FDA Emergency Use Authorization (EUA) for the BD Veritor(TM) At-Home COVID-19 Test - the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results. The test does not require a prescription, a laboratory, or a long wait for results. These kinds of product launches in the local markets drive the product demand in the market.
Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Lateral Flow Readers/Assay.
Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Lateral Flow Readers/Assay market during the forecast period.
Lateral Flow Readers/Assay Market Key Players:
Some of the key market players operating in the Lateral Flow Readers/Assay market include Abbott, Quidel Corporation, Danaher, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, Becton, Dickinson and Company, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc. (ADSTEC) and others.
Recent Developmental Activities in the Lateral Flow Readers/Assay Market:
On January 21, 2022, LumiraDx announced multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test was made available to patients in more than 30 nations worldwide.
On January 11, 2022, ADS Biotec announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company obtained a CE mark for the industry's first Rapid Antigen Test that works with both nasal swab and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.
On October 14, 2020, Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
Key Takeaways from the Lateral Flow Readers/Assay Market Report Study
Target Audience who can be benefited from this Lateral Flow Readers/Assay Market Report Study
Frequently Asked Questions for Lateral Flow Readers/Assay Market:
Lateral Flow Readers/Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. The most commonly known type of lateral flow rapid test strip is the pregnancy test.
Global Lateral Flow Readers/Assay Market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030.
The Lateral Flow Readers/Assay market is witnessing a positive market growth owing to the growing incidence of infectious diseases such as the sudden outbreak of COVID-19, and the increasing cases of pregnancy testing across the globe. Moreover, rapid technological advancements in the immunodiagnostic product arena, the rapidly aging population, increasing demand for point-of-care testing along with rising consumer awareness regarding quick diagnostics, among others.
Some of the key market players operating in the Lateral Flow Readers/Assay market include Abbott, Quidel Corporation, Danaher, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, Becton, Dickinson and Company, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc. (ADSTEC) and others.
North America is expected to hold the highest share in the revenue in the Lateral Flow Readers/Assay market during the forecast period. Factors such as the growing burden of infectious disease in the region, presence of key market players, rising demand for technologically advanced point-of-care diagnostics platforms, increasing awareness for early detection among others are expected to aid in the growth of North America Lateral Flow Readers/Assay Market.